Receptos Pharmaceuticals Obtains $25,000,000 Series A Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1464bc48-44b0-4a6e-b835-c69c4d997437&Preview=1 -
Date
11/23/2009 -
Company Name
Receptos Pharmaceuticals -
Mailing Address
10835 Road to the Cure San Diego, CA 92121 -
Company Description
Receptos is developing the next generation in GPCR drug discovery. -
Website
http://www.receptos.com -
Transaction Type
Venture Equity -
Transaction Amount
$25,000,000 -
Transaction Round
Series A -
Proceeds Purposes
The Series A capital will support the company’s lead sphingosine-1-phosphate receptor 1 (S1P1) clinical candidate through Phase 1 human clinical trials, development of a second IND candidate, as well as the select partnering of the proprietary technology platform for GPCR drug discovery and development. -
M&A Terms
-
Venture Investor
ARCH Venture Partners -
Venture Investor
Flagship Ventures -
Venture Investor
Lilly Ventures -
Venture Investor
Venrock
